BackPhoenix Biotech Acquisition Overview

Phoenix Biotech Acquisition Total Liabilities

Phoenix Biotech Acquisition's total liabilities is $11M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$11.46M
37.77% YoYΔ $3.14M vs prior year quarter

Peer average

Loading

Phoenix Biotech Acquisition Total Liabilities History

Loading

Phoenix Biotech Acquisition vs. peers: Total Liabilities Comparison

Loading

Phoenix Biotech Acquisition Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Phoenix Biotech Acquisition (PBAX) FAQ

As of the most recent data (March 2026), PBAX shows a total liabilities of $11M. That compares with $8.3M in the prior-year period — up 37.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PBAX's total liabilities is now $11M (was $8.3M) — a 37.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Phoenix Biotech Acquisition is outperforming or lagging.

Tracking PBAX's total liabilities over time shows whether Phoenix Biotech Acquisition is scaling, shrinking, or reshaping that part of the business. The current reading is $11M That compares with $8.3M in the prior-year period — up 37.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Phoenix Biotech Acquisition's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $11M) with ownership activity and broader fundamentals.